Skip to main content
Livermore
Livermore
ZHEN

Millennium Management LLC

SEC CIK
0001273087
Latest filing
Aug 14, 2026

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by Millennium Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings

Shares (Q2 2026)
1,170,787
Value
$43.6M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of CLDX by Millennium Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,170,787$43.6M<0.1%−82,745−6.6%ReducedHolders
Q1 20261,253,532$39.8M<0.1%+40,827+3.4%AddedHolders
Q4 20251,212,705$32.9M<0.1%+237,510+24.4%AddedHolders
Q3 2025975,195$25.2M<0.1%+497,968+104.3%AddedHolders
Q2 2025477,227$9.71M<0.1%+77,295+19.3%AddedHolders
Q1 2025399,932$7.26M<0.1%+306,330+327.3%AddedHolders
Q4 202493,602$2.37M<0.1%−14,501−13.4%ReducedHolders
Q3 2024108,103$3.67M<0.1%+64,353+147.1%AddedHolders
Q2 202443,750$1.62M<0.1%−164,501−79.0%ReducedHolders
Q1 2024208,251$8.74M<0.1%+197,254+1,793.7%AddedHolders
Q4 202310,997$436.1K<0.1%−147,160−93.0%ReducedHolders
Q3 2023158,157$4.35M<0.1%+137,417+662.6%AddedHolders
Q2 202320,740$703.7K<0.1%+20,740NewHolders
Q1 20230$00.0%−34,351−100.0%Sold outHolders
Q4 202234,351$1.53M<0.1%+34,351NewHolders
Q3 20220$00.0%−143,343−100.0%Sold outHolders
Q2 2022143,343$3.87M<0.1%+35,642+33.1%AddedHolders
Q1 2022107,701$3.67M<0.1%+68,030+171.5%AddedHolders
Q4 202139,671$1.53M<0.1%+39,671NewHolders
Q2 20210$00.0%−505,163−100.0%Sold outHolders
Q1 2021505,163$10.4M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.